Dispersome® Technology
Product Description
Zerion Pharma

-
DK
-
2021On CPHI since
-
1 - 24Employees
Company types
Categories
Zerion Pharma

-
DK
-
2021On CPHI since
-
1 - 24Employees
Company types
Zerion Pharma resources (9)
-
Brochure Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement
Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement for beta-lactoglobulin (Lacprodan® BLG-100) -
Video Dispersome® – an amorphous mixture
Technology that is changing the future
DISPERSOME®️ PLATFORM
Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.
IMPROVING OUTCOMESBy increasing solubility and dissolution rate the Dispersome®️ platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.
COMPATIBLE TECHNOLOGY
Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.
Frequently Viewed Together
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance